BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34297860)

  • 1. NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature.
    Gravesteijn G; Hack RJ; Mulder AA; Cerfontaine MN; van Doorn R; Hegeman IM; Jost CR; Rutten JW; Lesnik Oberstein SAJ
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12751. PubMed ID: 34297860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction.
    Hack RJ; Gravesteijn G; Cerfontaine MN; Santcroos MA; Gatti L; Kopczak A; Bersano A; Duering M; Rutten JW; Lesnik Oberstein SAJ
    Brain; 2023 Jul; 146(7):2913-2927. PubMed ID: 36535904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of
    Hack RJ; Cerfontaine MN; Gravesteijn G; Tap S; Hafkemeijer A; van der Grond J; Witjes-Ané MN; Baas F; Rutten JW; Lesnik Oberstein SAJ
    Stroke; 2022 Oct; 53(10):3133-3144. PubMed ID: 35862191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic
    Hack RJ; Gravesteijn G; Cerfontaine MN; Hegeman IM; Mulder AA; Lesnik Oberstein SAJ; Rutten JW
    Stroke; 2022 Jun; 53(6):1964-1974. PubMed ID: 35300531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad phenotype of cysteine-altering
    Rutten JW; Hack RJ; Duering M; Gravesteijn G; Dauwerse JG; Overzier M; van den Akker EB; Slagboom E; Holstege H; Nho K; Saykin A; Dichgans M; Malik R; Lesnik Oberstein SAJ
    Neurology; 2020 Sep; 95(13):e1835-e1843. PubMed ID: 32732295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.
    Rutten JW; Van Eijsden BJ; Duering M; Jouvent E; Opherk C; Pantoni L; Federico A; Dichgans M; Markus HS; Chabriat H; Lesnik Oberstein SAJ
    Genet Med; 2019 Mar; 21(3):676-682. PubMed ID: 30032161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.
    Gravesteijn G; Dauwerse JG; Overzier M; Brouwer G; Hegeman I; Mulder AA; Baas F; Kruit MC; Terwindt GM; van Duinen SG; Jost CR; Aartsma-Rus A; Lesnik Oberstein SAJ; Rutten JW
    Hum Mol Genet; 2020 Jul; 29(11):1853-1863. PubMed ID: 31960911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.
    Monet-Leprêtre M; Bardot B; Lemaire B; Domenga V; Godin O; Dichgans M; Tournier-Lasserve E; Cohen-Tannoudji M; Chabriat H; Joutel A
    Brain; 2009 Jun; 132(Pt 6):1601-12. PubMed ID: 19293235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of
    Cho BPH; Jolly AA; Nannoni S; Tozer D; Bell S; Markus HS
    Neurology; 2022 Aug; 99(5):e430-e439. PubMed ID: 35641310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients.
    Tikka S; Mykkänen K; Ruchoux MM; Bergholm R; Junna M; Pöyhönen M; Yki-Järvinen H; Joutel A; Viitanen M; Baumann M; Kalimo H
    Brain; 2009 Apr; 132(Pt 4):933-9. PubMed ID: 19174371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL.
    Ishiko A; Shimizu A; Nagata E; Takahashi K; Tabira T; Suzuki N
    Acta Neuropathol; 2006 Sep; 112(3):333-9. PubMed ID: 16871402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
    Abramycheva N; Stepanova M; Kalashnikova L; Zakharova M; Maximova M; Tanashyan M; Lagoda O; Fedotova E; Klyushnikov S; Konovalov R; Sakharova A; Illarioshkin S
    J Neurol Sci; 2015 Feb; 349(1-2):196-201. PubMed ID: 25623805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of
    Cerfontaine MN; Hack RJ; Gesierich B; Duering M; Witjes-Ané MW; Rodríguez-Girondo M; Gravesteijn G; Rutten J; Lesnik Oberstein SAJ
    Neurology; 2024 May; 102(10):e209310. PubMed ID: 38713890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice.
    Gravesteijn G; Munting LP; Overzier M; Mulder AA; Hegeman I; Derieppe M; Koster AJ; van Duinen SG; Meijer OC; Aartsma-Rus A; van der Weerd L; Jost CR; van den Maagdenberg AMJM; Rutten JW; Lesnik Oberstein SAJ
    Transl Stroke Res; 2020 Jun; 11(3):517-527. PubMed ID: 31667734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Mutation Outside of the EGFr Encoding Exons of NOTCH3 Gene in a Chinese with CADASIL.
    Wang W; Ren Z; Shi Y; Zhang J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105410. PubMed ID: 33254371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL.
    Muiño E; Gallego-Fabrega C; Cullell N; Carrera C; Torres N; Krupinski J; Roquer J; Montaner J; Fernández-Cadenas I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation.
    Rutten JW; Klever RR; Hegeman IM; Poole DS; Dauwerse HG; Broos LA; Breukel C; Aartsma-Rus AM; Verbeek JS; van der Weerd L; van Duinen SG; van den Maagdenberg AM; Lesnik Oberstein SA
    Acta Neuropathol Commun; 2015 Dec; 3():89. PubMed ID: 26715087
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cho BPH; Nannoni S; Harshfield EL; Tozer D; Gräf S; Bell S; Markus HS
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):694-701. PubMed ID: 33712516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].
    Ueda M; Nakaguma R; Ando Y
    Rinsho Byori; 2009 Mar; 57(3):242-51. PubMed ID: 19363995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro.
    Wollenweber FA; Hanecker P; Bayer-Karpinska A; Malik R; Bäzner H; Moreton F; Muir KW; Müller S; Giese A; Opherk C; Dichgans M; Haffner C; Duering M
    Stroke; 2015 Mar; 46(3):786-92. PubMed ID: 25604251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.